AJP - GI Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 281: G878-G889, 2001;
0193-1857/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pandak, W. M.
Right arrow Articles by Vlahcevic, Z. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pandak, W. M.
Right arrow Articles by Vlahcevic, Z. R.
Vol. 281, Issue 4, G878-G889, October 2001

Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasis

W. M. Pandak1, C. Schwarz1, P. B. Hylemon2, D. Mallonee2, K. Valerie1, D. M. Heuman1, R. A. Fisher3, Kaye Redford1, and Z. R. Vlahcevic1

Departments of 1 Medicine, 2 Microbiology, and 3 Surgery, Veterans Affairs Medical Center and Virginia Commonwealth University, Richmond, Virginia 23249

The initial and rate-limiting step in the classic pathway of bile acid biosynthesis is 7alpha -hydroxylation of cholesterol, a reaction catalyzed by cholesterol 7alpha -hydroxylase (CYP7A1). The effect of CYP7A1 overexpression on cholesterol homeostasis in human liver cells has not been examined. The specific aim of this study was to determine the effects of overexpression of CYP7A1 on key regulatory steps involved in hepatocellular cholesterol homeostasis, using primary human hepatocytes (PHH) and HepG2 cells. Overexpression of CYP7A1 in HepG2 cells and PHH was accomplished by using a recombinant adenovirus encoding a CYP7A1 cDNA (AdCMV-CYP7A1). CYP7A1 overexpression resulted in a marked activation of the classic pathway of bile acid biosynthesis in both PHH and HepG2 cells. In response, there was decreased HMG-CoA-reductase (HMGR) activity, decreased acyl CoA:cholesterol acyltransferase (ACAT) activity, increased cholesteryl ester hydrolase (CEH) activity, and increased low-density lipoprotein receptor (LDLR) mRNA expression. Changes observed in HMGR, ACAT, and CEH mRNA levels paralleled changes in enzyme specific activities. More specifically, LDLR expression, ACAT activity, and CEH activity appeared responsive to an increase in cholesterol degradation after increased CYP7A1 expression. Conversely, accumulation of the oxysterol 7alpha -hydroxycholesterol in the microsomes after CYP7A1 overexpression was correlated with a decrease in HMGR activity.

acyl-coenzyme A:cholesterol acyltransferase; cholesterol 7alpha -hydroxylase; 3-hydroxy-3-methyglutaryl-CoA reductase; low-density lipoprotein receptor; liver; neutral cholesterol ester hydrolase


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
S. Ren, P. Hylemon, Z.-P. Zhang, D. Rodriguez-Agudo, D. Marques, X. Li, H. Zhou, G. Gil, and W. M. Pandak
Identification of a novel sulfonated oxysterol, 5-cholesten-3{beta},25-diol 3-sulfonate, in hepatocyte nuclei and mitochondria
J. Lipid Res., May 1, 2006; 47(5): 1081 - 1090.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
B. Zhao, R. Natarajan, and S. Ghosh
Human liver cholesteryl ester hydrolase: cloning, molecular characterization, and role in cellular cholesterol homeostasis
Physiol Genomics, November 17, 2005; 23(3): 304 - 310.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
S. Ren, P. Hylemon, D. Marques, E. Hall, K. Redford, G. Gil, and W. M. Pandak
Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis
J. Lipid Res., November 1, 2004; 45(11): 2123 - 2131.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. L. West, T. Ramjiganesh, S. Roy, B. T. Keller, and M. L. Fernandez
1-[4-[4[(4R,5R)-3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]butyl]-4-aza-1-azoniabicyclo[2.2.2]octane Methanesulfonate (SC-435), an Ileal Apical Sodium-Codependent Bile Acid Transporter Inhibitor Alters Hepatic Cholesterol Metabolism and Lowers Plasma Low-Density Lipoprotein-Cholesterol Concentrations in Guinea Pigs
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 293 - 299.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online